Follow-up of conservatively managed prostate cancer Watchful waiting and primary hormonal therapy

Edward M. Messing, Ian Thompson

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

Many men with newly diagnosed prostate cancer choose not to undergo curative treatment, including patients who cannot be helped by local curative therapies (especially those with metastatic disease) and patients with clinically localized disease who opt for expectant management or noncurative treatments such as androgen ablation. This article reviews the selection of patients for these noncurative approaches, strategies for clinical monitoring, the choices of intervention therapies upon progression, and when to start these therapies.

Original languageEnglish (US)
Pages (from-to)687-702
Number of pages16
JournalUrologic Clinics of North America
Volume30
Issue number4
DOIs
StatePublished - Nov 2003

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Follow-up of conservatively managed prostate cancer Watchful waiting and primary hormonal therapy'. Together they form a unique fingerprint.

Cite this